Michihiko Takesue

435 total citations
18 papers, 355 citations indexed

About

Michihiko Takesue is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Michihiko Takesue has authored 18 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 8 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Michihiko Takesue's work include Liver physiology and pathology (7 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Michihiko Takesue is often cited by papers focused on Liver physiology and pathology (7 papers), Organ Transplantation Techniques and Outcomes (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Michihiko Takesue collaborates with scholars based in Japan. Michihiko Takesue's co-authors include Shinichiro Yamamoto, Norikuni Shibata, Kenji Ohmoto, Teru Okitsu, Naoya Kobayashi, Noriaki Tanaka, Toshinori Totsugawa, Masakiyo Sakaguchi, Makoto Kuboki and Hirofumi Noguchi and has published in prestigious journals such as Transplantation, American Journal of Roentgenology and Digestive Diseases and Sciences.

In The Last Decade

Michihiko Takesue

16 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michihiko Takesue Japan 13 205 157 99 96 37 18 355
Jung‐Chin Chang Netherlands 11 115 0.6× 111 0.7× 75 0.8× 130 1.4× 62 1.7× 23 336
R A Faris United States 10 229 1.1× 197 1.3× 70 0.7× 164 1.7× 96 2.6× 12 438
Niya Aleksieva United Kingdom 5 204 1.0× 167 1.1× 94 0.9× 138 1.4× 42 1.1× 6 401
Hubert Y. Luu United States 6 220 1.1× 228 1.5× 97 1.0× 141 1.5× 58 1.6× 11 409
Andrew Y. Lee United States 6 138 0.7× 134 0.9× 53 0.5× 258 2.7× 20 0.5× 8 418
Max A. Cayo United States 8 75 0.4× 128 0.8× 43 0.4× 257 2.7× 46 1.2× 10 397
Xuzhen Yan China 10 121 0.6× 66 0.4× 125 1.3× 129 1.3× 53 1.4× 18 337
Chengang Xiang China 8 135 0.7× 152 1.0× 29 0.3× 358 3.7× 19 0.5× 11 539
Milad Rezvani United States 8 431 2.1× 366 2.3× 173 1.7× 317 3.3× 64 1.7× 17 803
Georg A. Mathis Switzerland 11 147 0.7× 141 0.9× 49 0.5× 157 1.6× 160 4.3× 19 391

Countries citing papers authored by Michihiko Takesue

Since Specialization
Citations

This map shows the geographic impact of Michihiko Takesue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michihiko Takesue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michihiko Takesue more than expected).

Fields of papers citing papers by Michihiko Takesue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michihiko Takesue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michihiko Takesue. The network helps show where Michihiko Takesue may publish in the future.

Co-authorship network of co-authors of Michihiko Takesue

This figure shows the co-authorship network connecting the top 25 collaborators of Michihiko Takesue. A scholar is included among the top collaborators of Michihiko Takesue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michihiko Takesue. Michihiko Takesue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ohmoto, Kenji, Naoko Yoshioka, Yasuyuki Tomiyama, et al.. (2006). Improved Prognosis of Cirrhosis Patients with Esophageal Varices and Thrombocytopenia Treated by Endoscopic Variceal Ligation Plus Partial Splenic Embolization. Digestive Diseases and Sciences. 51(2). 352–358. 31 indexed citations
2.
Shibata, Norikuni, Michihiko Takesue, Kenji Ohmoto, et al.. (2005). Five cases of hepatocellular carcinoma with more than ten years survival. Kanzo. 46(6). 372–381.
3.
Takesue, Michihiko, Karen A. Westerman, Teru Okitsu, et al.. (2004). ESTABLISHMENT OF AN IMMORTALIZED HUMAN-LIVER ENDOTHELIAL CELL LINE WITH SV40T AND hTERT. Transplantation. 77(9). 1357–1365. 73 indexed citations
4.
Maruyama, Masanobu, Toshinori Totsugawa, Teru Okitsu, et al.. (2003). Hepatocyte Isolation and Transplantation in the Pig. Cell Transplantation. 12(6). 593–598. 32 indexed citations
5.
Kobayashi, Naoya, Masakiyo Sakaguchi, Teru Okitsu, et al.. (2003). Active expression of p21 facilitates differentiation of immortalized human hepatocytes. Transplantation Proceedings. 35(1). 433–434. 4 indexed citations
6.
Shibata, Norikuni, Takamasa Watanabe, Teru Okitsu, et al.. (2003). Establishment of an Immortalized Human Hepatic Stellate Cell Line to Develop Antifibrotic Therapies. Cell Transplantation. 12(5). 499–507. 44 indexed citations
7.
Maruyama, Masanobu, Teru Okitsu, Norikuni Shibata, et al.. (2003). Cryopreservation of Primarily Isolated Porcine Hepatocytes with UW Solution. Cell Transplantation. 12(6). 607–616. 29 indexed citations
8.
Kobayashi, Naoya, Michihiko Takesue, Naoya Kobayashi, et al.. (2003). Evaluation of toll-like receptor 4 gene expression of immortalized human liver cell lines. Transplantation Proceedings. 35(1). 431–432. 4 indexed citations
9.
Takesue, Michihiko, Masanobu Maruyama, Norikuni Shibata, et al.. (2003). Maintenance of Cold-Preserved Porcine Hepatocyte Function with UW Solution and Ascorbic Acid-2 Glucoside. Cell Transplantation. 12(6). 599–606. 16 indexed citations
10.
Kobayashi, Naoya, Masakiyo Sakaguchi, Teru Okitsu, et al.. (2002). Transduction of Immortalized Human Hepatocytes with p21 to Enhance Differentiated Phenotypes. Cell Transplantation. 11(5). 421–428. 14 indexed citations
11.
Ohmoto, Kenji, Mitsuyoshi Hirokawa, Michihiko Takesue, & Shinichiro Yamamoto. (2001). Hepatic angiosarcoma with early central enhancement and arterioportal shunt on dynamic CT.. PubMed. 47(36). 1717–8. 13 indexed citations
12.
Katsura, Masashi, et al.. (2001). NMDA receptor activation enhances diazepam binding inhibitor and its mRNA expressions in mouse cerebral cortical neurons. Molecular Brain Research. 88(1-2). 161–165. 7 indexed citations
13.
Katsura, Masashi, et al.. (2001). Suppression of Ca2+ influx through L-type voltage-dependent calcium channels by hydroxyl radical in mouse cerebral cortical neurons. Molecular Brain Research. 92(1-2). 12–18. 15 indexed citations
14.
Katsura, Masashi, et al.. (2000). Mechanism for increase in expression of cerebral diazepam binding inhibitor mRNA by nicotine: involvement of L-type voltage-dependent calcium channels. Molecular Brain Research. 80(2). 132–141. 12 indexed citations
15.
Ohmoto, Kenji, Norikuni Shibata, Michihiko Takesue, et al.. (2000). Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma.. PubMed. 46(29). 2894–900. 33 indexed citations
16.
Ohmoto, Kenji, et al.. (1999). Percutaneous microwave coagulation therapy for hepatocellular carcinoma located on the surface of the liver.. American Journal of Roentgenology. 173(5). 1231–1233. 15 indexed citations
17.
Yamamoto, S, Y. Iguchi, Nobuhiro Shibata, et al.. (1998). [Percutaneous ethanol and acetic acid injection for liver metastasis from colon cancer--two case reports].. PubMed. 25(5). 751–5.
18.
Kōyama, Yutaka, Akira Awaya, Keiichi Yokoyama, et al.. (1997). Neurotropic Pyrimidine Heterocyclic Compounds. II. Effects of Novel Neurotropic Pyrimidine Derivatives on Astrocytic Morphological Differentiation.. Biological and Pharmaceutical Bulletin. 20(2). 138–141. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jung‐Chin Chang Breakdown of academic impact, for papers by R A Faris Breakdown of academic impact, for papers by Niya Aleksieva Breakdown of academic impact, for papers by Hubert Y. Luu Breakdown of academic impact, for papers by Andrew Y. Lee Breakdown of academic impact, for papers by Max A. Cayo Breakdown of academic impact, for papers by Xuzhen Yan Breakdown of academic impact, for papers by Chengang Xiang Breakdown of academic impact, for papers by Milad Rezvani Breakdown of academic impact, for papers by Georg A. Mathis
Rankless by CCL
2026